Enzymatic activity of 38 CYP2C9 genotypes on ibuprofen
Ling-Jing Yuan,Xiang-Yu Li,Feng Ye,Xin-Yue Li,Qing-Qing Li,Yun-Shan Zhong,Shi-Yu Wang,Ya-Hui Wang,Guo-Xin Hu,Jian-Ping Cai,Jun-Wei Li,Ling-jing Yuan,Xiang-yu Li,Xin-yue Li,Qing-qing Li,Yun-shan Zhong,Shi-yu Wang,Ya-hui Wang,Guo-xin Hu,Jian-ping Cai,Jun-wei Li
DOI: https://doi.org/10.1016/j.fct.2023.113926
IF: 4.3
2023-07-05
Food and Chemical Toxicology
Abstract:Background and objective Ibuprofen, a common non-steroidal anti-inflammatory drug, is used clinically for pain relief and antipyretic treatment worldwide. However, regular or long-term use of ibuprofen may lead to a series of adverse reactions, including gastrointestinal bleeding, hypertension and kidney injury. Previous studies have shown that CYP2C9 gene polymorphism plays an important role in the elimination of various drugs, which leads to the variation in drug efficacy. This study aimed to evaluate the effect of 38 CYP2C9 genotypes on ibuprofen metabolism. Methods Thirty-eight recombinant human CYP2C9 microsomal enzymes were obtained using a frugiperda 21 insect expression system according to a previously described method. Assessment of the catalytic function of these variants was completed via a mature incubation system: 5 pmol CYP2C9*1 and 38 CYP2C9 variants recombinant human microsomes, 5 μL cytochrome B5, ibuprofen (5–1000 μM), and Tris-HCl buffer (pH 7.4). The ibuprofen metabolite contents were determined using HPLC analysis. HPLC analysis included a UV detector, Plus-C18 column, and mobile phase [50% acetonitrile and 50% water (containing 0.05% trifluoroacetic acid)]. The kinetic parameters of the CYP2C9 genotypes were obtained by Michaelis-Menten curve fitting. Results The intrinsic clearance (CL int ) of eight variants was not significantly different from CYP2C9*1; four CYP2C9 variants (CYP2C9*38, *44, *53 and *59) showed significantly higher CL int (increase by 35%–230%) than that of the wild-type; the remaining twenty-six variants exhibited significantly reduced CL int (reduced by 30%–99%) compared to that of the wild-type. Conclusion This is the first systematic evaluation of the catalytic characteristics of 38 CYP2C9 genotypes involved ibuprofen metabolism. Our results provide a corresponding supplement to studies on CYP2C9 gene polymorphisms and kinetic characteristics of different variants. We need to focus on poor metabolizers (PMs) with severely abnormal metabolic functions, because they are more susceptible to drug exposure.
toxicology,food science & technology